We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-4.13%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.23B
AUM Growth
-$45.6M
Cap. Flow
+$38.1M
Cap. Flow %
3.09%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
3
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$32.2M
2
IMDX
Insight Molecular Diagnostics
IMDX
+$14M
3
OLO
Olo Inc
OLO
+$12.4M
4
LCTX icon
Lineage Cell Therapeutics
LCTX
+$4.63M

Top Sells

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$15.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$9.76M

Sector Composition

Rank Sector Weight
1 Consumer Staples 39.33%
2 Industrials 29.66%
3 Healthcare 22.47%
4 Technology 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$485M 39.33%
8,295,690
– –
AXON
2
Axon Enterprise
AXON
$42.5B
$366M 29.66%
696,075
-26,346
-4% -$15.4M
STAA icon
3
STAAR Surgical
STAA
$1.21B
$220M 17.79%
12,455,264
+1,606,633
+15% +$32.2M
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$94.7M 7.67%
474,920
-45,000
-9% -$9.76M
IMDX
5
Insight Molecular Diagnostics
IMDX
$150M
$34.9M 2.83%
11,410,100
+5,165,695
+83% +$14M
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$269M
$22.4M 1.81%
49,560,992
+7,894,737
+19% +$4.63M
OLO
7
DELISTED
Olo Inc
OLO
$10.8M 0.87%
+1,782,334
New +$12.4M
SER icon
8
Serina Therapeutics
SER
$30M
$483K 0.04%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Broadwood Capital held 8 positions worth $1.23B, down 3.6% from $1.28B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital deployed $38.1M of net new capital in Q1 2025, opening 1 new position and adding to 3 existing holdings. Its largest new stake was Olo Inc: 1,782,334 shares worth $10.8M.

By sector, the portfolio is most concentrated in Consumer Staples at 39% of assets, up from 34% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Axon Enterprise, an estimated $15.4M trimmed.

  • Broadwood Capital's largest Q1 2025 buy was Olo Inc: 1,782,334 shares worth $10.8M.
  • Broadwood Capital added most to STAAR Surgical in Q1 2025, an estimated $32.2M increase.
  • Broadwood Capital's biggest Q1 2025 reduction was Axon Enterprise, cutting an estimated $15.4M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.23B portfolio in Q1 2025.
  • Broadwood Capital opened 1 new position and closed 0 in Q1 2025.
  • Broadwood Capital's portfolio value fell 3.6% quarter-over-quarter to $1.23B.

Based on Broadwood Capital's 13F filing for Q1 2025, filed 15 May 2025.